US BROKER MOVES: CRWD upgraded at Piper Sandler; OWL downgraded at Barclays

UPGRADES Aehr Test Systems (AEHR) upgraded from Neutral to Outperform at William Blair AppLovin (APP) upgraded from Sell to Neutral at Arete; PT USD 340 CrowdStrike (CRWD) upgraded from Neutral to Overweight at Piper Sandler; PT USD 520 Dorman Products (DORM) upgraded from Hold to Buy at Jefferies; PT USD 140 Dutch Bros (BROS) upgraded from Neutral to Buy at Goldman; PT USD 75 First American (FAF) upgraded from Equal-Weight to Overweight at Stephens; PT USD 81 Flywire (FLYW) upgraded from Equalweight to Overweight at Morgan Stanley; PT USD 17 Frontdoor (FTDR) upgraded from Sell to Neutral at Goldman; PT USD 67 Hyster-Yale (HY) upgraded from Market Perform to Outperform at Northland; PT USD 50 JetBlue (JBLU) upgraded from Underweight to Equal-Weight at Barclays Netflix (NFLX) upgraded from Neutral to Overweight at JPMorgan; PT USD 120 South Plains (SPFI) upgraded from Neutral to Overweight at Piper Sandler; PT USD 48 StepStone (STEP) upgraded from Equal-Weight to Overweight at Barclays; PT USD 55 Twilio (TWLO) upgraded from Hold to Buy at TD Cowen; PT USD 160 Zions (ZION) upgraded from Equal-Weight to Overweight at Morgan Stanley; PT USD 75 DOWNGRADES Aardvark Therapeutics (AARD) downgraded from Buy to Neutral at H.C. Wainwright Aardvark Therapeutics (AARD) downgraded from Overweight to Equal-Weight at Morgan Stanley Aardvark Therapeutics (AARD) downgraded from Outperform to Sector Perform at RBC; PT USD 6 Aardvark Therapeutics (AARD) downgraded from Buy to Hold at Stifel; PT USD 6 Arcellx (ACLX) downgraded from Buy to Hold at TD Cowen AZZ (AZZ) downgraded from Overweight to Equal-Weight at Wells Fargo; PT USD 132 Blue Owl Capital (OWL) downgraded from Overweight to Equal-Weight at Barclays; PT USD 11 Fiverr (FVRR) downgraded from Buy to Neutral at BTIG Frontier Airlines (ULCC) downgraded from Equal-Weight to Underweight at Barclays GitLab (GTLB) downgraded from Buy to Hold at TD Cowen; PT USD 29 Novo (NVO) downgraded from Buy to Neutral at Goldman; PT USD 41 Playtika (PLTK) downgraded from Buy to Neutral at Wedbush; PT USD 3 SITE Centers (SITC) downgraded from Overweight to Neutral at Piper Sandler; PT USD 6.50 INITIATIONS Bob's Discount Furniture (BOBS) initiated at Outperform at Raymond James Bob's Discount Furniture (BOBS) initiated at Buy at Loop Capital; PT USD 28 Bob's Discount Furniture (BOBS) initiated at Neutral at Baird; PT USD 22 Bob's Discount Furniture (BOBS) initiated at Overweight at Morgan Stanley Bob's Discount Furniture (BOBS) initiated at Outperform at RBC; PT USD 26 Bob's Discount Furniture (BOBS) initiated at Overweight at JPMorgan Bob's Discount Furniture (BOBS) initiated at Neutral at Goldman; PT USD 25 Bob's Discount Furniture (BOBS) initiated at Overweight at KeyBanc; PT USD 28 Bob's Discount Furniture (BOBS) initiated at Buy at UBS; PT USD 27 Didi Global (DIDIY) ADRs initiated at Buy at UOB Kay Hian; PT USD 6.60 Dynatrace (DT) initiated at Neutral at Macquarie; PT USD 36 Eikon Therapeutics (EIKN) initiated at Overweight at Cantor Eikon Therapeutics (EIKN) initiated at Outperform at Mizuho Securities Eikon Therapeutics (EIKN) initiated at Overweight at Morgan Stanley Eikon Therapeutics (EIKN) initiated at Overweight at JPMorgan; PT USD 29 Forgent Power Solutions (FPS) initiated at Outperform at Oppenheimer Forgent Power Solutions (FPS) initiated at Buy at TD Cowen; PT USD 45 Forgent Power Solutions (FPS) initiated at Equal-Weight at Morgan Stanley Forgent Power Solutions (FPS) initiated at Overweight at Barclays; PT USD 44 Forgent Power Solutions (FPS) initiated at Overweight at JPMorgan; PT USD 40 Forgent Power Solutions (FPS) initiated at Overweight at KeyBanc; PT USD 41 Forgent Power Solutions (FPS) initiated at Buy at Jefferies; PT USD 44 Forgent Power Solutions (FPS) initiated at Buy at Goldman; PT USD 48 NextTrip (NTRP) initiated at Buy at Ascendiant Capital; PT USD 7 Regentis Biomaterials (RGNT) initiated at Buy at ThinkEquity; PT USD 10 Relmada Therapeutics (RLMD) initiated at Buy at Lucid Capital Markets VeraDermics (MANE) initiated at Outperform at Leerink; PT USD 75 VeraDermics (MANE) initiated at Buy at Citi; PT USD 85 VeraDermics (MANE) initiated at Buy at Jefferies; PT USD 75 VeraDermics (MANE) initiated at Overweight at Cantor Versant Media (VSNT) initiated at Hold at TD Cowen; PT USD 32